Melissa Anne Daubert

Conference European Heart Journal · November 5, 2025 AbstractBackgroundThe American Heart Association PREVENT cardiovascular disease (CVD) risk score predicts heart failure (HF) an ... Full text Cite

VALVULAR HEART DISEASE IN RURAL COUNTIES: RESULTS FROM THE WILCOX AND OKTIBBEHA SITES OF THE RURAL COHORT STUDY

Conference JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · April 1, 2025 Link to item Cite

Abstract 4146849: Reassessing Thresholds for Pulmonary Hypertension in Healthy and Early Stage Heart Failure - Project Baseline Health Study

Conference Circulation · November 12, 2024 Background: There is increasing evidence that current thresholds for diagnosing pulmonary hypertension (PH) may underestimate its prevalence and importance in clinical practice. ... Full text Cite

Anatomic and Functional Discordance Among Patients With Nonobstructive Coronary Disease.

Conference JACC Cardiovasc Imaging · June 2024 Full text Link to item Cite

CLINICAL AND ECHOCARDIOGRAPHIC DIVERSITY ASSOCIATED WITH PHYSICAL FITNESS: THE PROJECT BASELINE HEALTH STUDY

Conference JOURNAL OF HYPERTENSION · June 2023 Link to item Cite

Six Month Patency of Bioengineered Human Acellular Vessels in a Primate Model of Coronary Artery Bypass Grafting

Conference CIRCULATION · November 8, 2022 Link to item Cite

Echocardiographic diversity associated with exercise capacity in heart failure precursor stage B: the Project Baseline Health Study

Conference EUROPEAN HEART JOURNAL · October 2022 Link to item Cite

Anatomic and functional discordance among patients with non-obstructive coronary disease

Conference EUROPEAN HEART JOURNAL · October 2022 Link to item Cite

Abstract P1017: Tissue Engineered Human Acellular Blood Vessels For Coronary Artery Bypass Grafting

Conference Circulation Research · August 5, 2022 Objective: Conduit for coronary artery bypass grafting (CABG) can be limited due to poor quality or prior removal of saphenous veins. A human acellular vessel (HAV) bioengineered from vascular cells a ... Full text Cite

TCT-140 Impact of Left Ventricular Mass Regression on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER 1 and 2 Trials and Registries

Conference Journal of the American College of Cardiology · October 2019 Full text Cite

TCT-74 Baseline Left Ventricular Hypertrophy and 5-Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries

Conference Journal of the American College of Cardiology · October 2019 Full text Cite

The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial.

Conference JACC Cardiovasc Imaging · December 2018 Full text Link to item Cite

Predictors and Outcomes of Reverse Remodeling in Heart Failure With Reduced Ejection Fraction

Conference CIRCULATION · November 6, 2018 Link to item Cite

Biomarker-Guided Heart Failure Therapy Results in Significant Reverse Left Ventricular Remodeling Among Patients Achieving NT-proBNP Goal: Insights From the GUIDE-IT Trial

Conference CIRCULATION · November 14, 2017 Link to item Cite

Treatment of Sleep-Disordered Breathing and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction: Insights From the CAT-HF Trial

Conference CIRCULATION · November 11, 2016 Link to item Cite

EFFECTS OF A NOVEL TETRAPEPTIDE IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PHASE I RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ELAMIPRETIDE

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

SEX DIFFERENCES IN DEMOGRAPHICS, RISK FACTORS AND PRESENTATION IN STABLE CONTEMPORARY OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROMISE TRIAL

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

EVALUATION OF LEFT VENTRICULAR ASSIST DEVICE DYSFUNCTION BY CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY

Conference Journal of the American College of Cardiology · April 2016 Full text Cite

TRANSCATHETER AORTIC VALVE REPLACEMENT RESULTS IN SIGNIFICANT REVERSE REMODELING IN PATIENTS WITH LEFT VENTRICULAR DILATION: A REPORT FROM THE PARTNER I TRIAL

Conference Journal of the American College of Cardiology · March 2015 Full text Cite

Melissa Anne Daubert

Scholarly Works - Conferences

DIFFUSE CORONARY ARTERY DISEASE DISTRIBUTION CARRIES PROGNOSTIC VALUE IN PATIENTS WITH STABLE CHEST PAIN: INSIGHTS FROM THE PROMISE TRIAL

The added value of ECG on the PREVENT CVD risk score for the prediction of subclinical cardiac disease - insights from Project Baseline Health Study

VALVULAR HEART DISEASE IN RURAL COUNTIES: RESULTS FROM THE WILCOX AND OKTIBBEHA SITES OF THE RURAL COHORT STUDY

Abstract 4146849: Reassessing Thresholds for Pulmonary Hypertension in Healthy and Early Stage Heart Failure - Project Baseline Health Study

Anatomic and Functional Discordance Among Patients With Nonobstructive Coronary Disease.

CLINICAL AND ECHOCARDIOGRAPHIC DIVERSITY ASSOCIATED WITH PHYSICAL FITNESS: THE PROJECT BASELINE HEALTH STUDY

Six Month Patency of Bioengineered Human Acellular Vessels in a Primate Model of Coronary Artery Bypass Grafting

Echocardiographic diversity associated with exercise capacity in heart failure precursor stage B: the Project Baseline Health Study

Anatomic and functional discordance among patients with non-obstructive coronary disease

Abstract P1017: Tissue Engineered Human Acellular Blood Vessels For Coronary Artery Bypass Grafting

Angiopoetin 2 Predicts Clinical Outcomes And Recovery Of Ventricular Function In Heart Failure

The Influence of Obesity on Coronary Artery Disease and Clinical Outcomes in the ADVANCE Registry

POSTPARTUM BLOOD PRESSURE SCREENING IN WOMEN WITH HYPERTENSIVE DISORDERS OF PREGNANCY

TCT-140 Impact of Left Ventricular Mass Regression on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER 1 and 2 Trials and Registries

TCT-74 Baseline Left Ventricular Hypertrophy and 5-Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries

The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial.

Predictors and Outcomes of Reverse Remodeling in Heart Failure With Reduced Ejection Fraction

Biomarker-Guided Heart Failure Therapy Results in Significant Reverse Left Ventricular Remodeling Among Patients Achieving NT-proBNP Goal: Insights From the GUIDE-IT Trial

Treatment of Sleep-Disordered Breathing and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction: Insights From the CAT-HF Trial

EFFECTS OF A NOVEL TETRAPEPTIDE IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PHASE I RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ELAMIPRETIDE

SEX DIFFERENCES IN DEMOGRAPHICS, RISK FACTORS AND PRESENTATION IN STABLE CONTEMPORARY OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROMISE TRIAL

EVALUATION OF LEFT VENTRICULAR ASSIST DEVICE DYSFUNCTION BY CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY

TRANSCATHETER AORTIC VALVE REPLACEMENT RESULTS IN SIGNIFICANT REVERSE REMODELING IN PATIENTS WITH LEFT VENTRICULAR DILATION: A REPORT FROM THE PARTNER I TRIAL